Kezar Life Sciences, Inc. (KZR) Social Stream



Kezar Life Sciences, Inc. (KZR): $8.97

0.05 (+0.56%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KZR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 505

in industry

Kezar Life Sciences Inc (KZR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering KZR.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $18 $12 $15 $8.92 68.16%

The Trend in the Analyst Price Target


KZR's average price target has moved up $0.33 over the prior 163 days.

KZR reports an average of 154.92% for its upside potential over the past 13 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-12 3 18 12 15.00 5.61 167.38%
2021-07-10 3 18 12 15.00 5.77 159.97%
2021-06-14 3 18 12 15.00 5.78 159.52%
2021-06-13 3 18 12 15.00 5.64 165.96%
2021-06-05 3 18 12 15.00 5.57 169.3%
2021-04-22 3 18 12 15.00 5.65 165.49%
2021-03-23 3 18 12 15.00 6.73 122.88%
2021-03-20 3 18 12 15.00 6.40 134.37%
2021-02-04 3 18 12 14.67 5.36 173.69%
2021-01-30 3 18 12 14.67 5.31 176.27%
2020-12-10 3 18 12 14.67 5.57 163.38%
2020-12-07 3 18 12 14.67 6.05 142.48%
2020-11-23 3 18 12 14.67 6.00 144.5%
2020-10-20 4 18 8 13.00 5.81 123.75%
2020-08-17 3 18 12 14.67 NA NA%
2020-08-06 3 18 12 14.67 NA NA%
2020-07-05 3 18 12 15.33 NA NA%
2020-06-03 4 18 12 16.00 NA NA%

KZR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.3 2 3 0 0 0 5

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • KZR has a higher upside potential (average analyst target price relative to current price) than 75.68% of all US stocks.
  • KZR has a greater number of analysts covering the stock than 26.64% of all US stocks.
  • Kezar Life Sciences Inc's average analyst price target is higher than 28.42% of all US stocks.
  • Kezar Life Sciences Inc's variance in analysts' estimates is lower than 28.88% of stocks in the small market cap category.

In the Pharmaceutical Products industry, ALPN, GHRS and AVTE are the three stocks most similar to Kezar Life Sciences Inc regarding the price target and analyst recommendation information presented here.

Is KZR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6218 seconds.